<VariationArchive VariationID="424445" VariationName="NM_000487.6(ARSA):c.302del (p.Gly101fs)" VariationType="Deletion" Accession="VCV000424445" Version="6" RecordType="classified" NumberOfSubmissions="3" NumberOfSubmitters="3" DateLastUpdated="2024-02-28" DateCreated="2017-04-27" MostRecentSubmission="2024-02-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="411049" VariationID="424445">
      <GeneList>
        <Gene Symbol="ARSA" FullName="arylsulfatase A" GeneID="410" HGNC_ID="HGNC:713" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>22q13.33</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="22" Accession="NC_000022.11" start="50622754" stop="50628152" display_start="50622754" display_stop="50628152" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="22" Accession="NC_000022.10" start="51061181" stop="51066600" display_start="51061181" display_stop="51066600" Strand="-" />
          </Location>
          <OMIM>607574</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000487.6(ARSA):c.302del (p.Gly101fs)</Name>
      <CanonicalSPDI>NC_000022.11:50627328:CCCCCCC:CCCCCC</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>22q13.33</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="22" Accession="NC_000022.11" start="50627329" stop="50627329" display_start="50627329" display_stop="50627329" variantLength="1" positionVCF="50627328" referenceAlleleVCF="GC" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="22" Accession="NC_000022.10" start="51065757" stop="51065757" display_start="51065757" display_stop="51065757" variantLength="1" positionVCF="51065756" referenceAlleleVCF="GC" alternateAlleleVCF="G" />
      </Location>
      <ProteinChange>G101fs</ProteinChange>
      <ProteinChange>G15fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000022.10" sequenceAccession="NC_000022" sequenceVersion="10" change="g.51065763del" Assembly="GRCh37">
            <Expression>NC_000022.10:g.51065763del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000022.11" sequenceAccession="NC_000022" sequenceVersion="11" change="g.50627335del" Assembly="GRCh38">
            <Expression>NC_000022.11:g.50627335del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009260.2" sequenceAccession="NG_009260" sequenceVersion="2" change="g.5851del">
            <Expression>NG_009260.2:g.5851del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000487.6" sequenceAccession="NM_000487" sequenceVersion="6" change="c.302del" MANESelect="true">
            <Expression>NM_000487.6:c.302del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000478.3" sequenceAccession="NP_000478" sequenceVersion="3" change="p.Gly101fs">
            <Expression>NP_000478.3:p.Gly101fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001085425.3" sequenceAccession="NM_001085425" sequenceVersion="3" change="c.302del">
            <Expression>NM_001085425.3:c.302del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001078894.2" sequenceAccession="NP_001078894" sequenceVersion="2" change="p.Gly101fs">
            <Expression>NP_001078894.2:p.Gly101fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001085426.3" sequenceAccession="NM_001085426" sequenceVersion="3" change="c.302del">
            <Expression>NM_001085426.3:c.302del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001078895.2" sequenceAccession="NP_001078895" sequenceVersion="2" change="p.Gly101fs">
            <Expression>NP_001078895.2:p.Gly101fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001085427.3" sequenceAccession="NM_001085427" sequenceVersion="3" change="c.302del">
            <Expression>NM_001085427.3:c.302del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001078896.2" sequenceAccession="NP_001078896" sequenceVersion="2" change="p.Gly101fs">
            <Expression>NP_001078896.2:p.Gly101fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001085428.3" sequenceAccession="NM_001085428" sequenceVersion="3" change="c.44del">
            <Expression>NM_001085428.3:c.44del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001078897.1" sequenceAccession="NP_001078897" sequenceVersion="1" change="p.Gly15fs">
            <Expression>NP_001078897.1:p.Gly15fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001362782.2" sequenceAccession="NM_001362782" sequenceVersion="2" change="c.44del">
            <Expression>NM_001362782.2:c.44del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001349711.1" sequenceAccession="NP_001349711" sequenceVersion="1" change="p.Gly15fs">
            <Expression>NP_001349711.1:p.Gly15fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA10325059" DB="ClinGen" />
        <XRef Type="rs" ID="761606317" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000487.6(ARSA):c.302del (p.Gly101fs) AND not provided" Accession="RCV000483135" Version="5">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2017-03-16" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000487.6(ARSA):c.302del (p.Gly101fs) AND Metachromatic leukodystrophy" Accession="RCV003607294" Version="1">
        <ClassifiedConditionList TraitSetID="787">
          <ClassifiedCondition DB="MedGen" ID="C0023522">Metachromatic leukodystrophy</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-10-22" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-10-22" NumberOfSubmissions="3" NumberOfSubmitters="3" DateCreated="2017-04-27" MostRecentSubmission="2024-02-20">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">10477432</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">8962139</ID>
        </Citation>
        <Citation Type="general">
          <URL>http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=ARSA</URL>
        </Citation>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="787" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5508" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Arylsulfatase A Deficiency</ElementValue>
                <XRef ID="NBK1130" DB="GeneReviews" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Metachromatic leukodystrophy</ElementValue>
                <XRef ID="Metachromatic+leukodystrophy/4691" DB="Genetic Alliance" />
                <XRef ID="MONDO:0018868" DB="MONDO" />
                <XRef ID="396338004" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Metachromatic leukoencephalopathy</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Sulfatide lipidosis</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cerebral sclerosis diffuse metachromatic form</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cerebroside sulfatase deficiency</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">MLD</ElementValue>
                <XRef Type="MIM" ID="250100" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Arylsulfatase A deficiency (also known as metachromatic leukodystrophy or MLD) is characterized by three clinical subtypes: late-infantile MLD, juvenile MLD, and adult MLD. Age of onset within a family is usually similar. The disease course may be from several years in the late-infantile-onset form to decades in the juvenile- and adult-onset forms. Late-infantile MLD. Onset is before age 30 months. Typical presenting findings include weakness, hypotonia, clumsiness, frequent falls, toe walking, and dysarthria. As the disease progresses, language, cognitive, and gross and fine motor skills regress. Later signs include spasticity, pain, seizures, and compromised vision and hearing. In the final stages, children have tonic spasms, decerebrate posturing, and general unawareness of their surroundings. Juvenile MLD. Onset is between age 30 months and 16 years. Initial manifestations include decline in school performance and emergence of behavioral problems, followed by gait disturbances. Progression is similar to but slower than in the late-infantile form. Adult MLD. Onset occurs after age 16 years, sometimes not until the fourth or fifth decade. Initial signs can include problems in school or job performance, personality changes, emotional lability, or psychosis; in others, neurologic symptoms (weakness and loss of coordination progressing to spasticity and incontinence) or seizures initially predominate. Peripheral neuropathy is common. Disease course is variable – with periods of stability interspersed with periods of decline – and may extend over two to three decades. The final stage is similar to earlier-onset forms.</Attribute>
                <XRef ID="NBK1130" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="3230" />
                <XRef ID="3230" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301309</ID>
                <ID Source="BookShelf">NBK1130</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="AAP, 2021">
                <URL>https://publications.aap.org/pediatrics/article/148/3/e2021053126/181065/Leukodystrophies-in-Children-Diagnosis-Care-and</URL>
                <CitationText>Leukodystrophies in Children: Diagnosis, Care, and Treatment, Pediatrics (2021) 148 (3): e2021053126.</CitationText>
              </Citation>
              <XRef ID="512" DB="Orphanet" />
              <XRef ID="C0023522" DB="MedGen" />
              <XRef ID="MONDO:0018868" DB="MONDO" />
              <XRef Type="MIM" ID="250100" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1377095" SubmissionDate="2018-09-19" DateLastUpdated="2018-12-15" DateCreated="2018-04-02">
        <ClinVarSubmissionID localKey="57925_000000" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000704696" DateUpdated="2018-12-15" DateCreated="2018-04-02" Type="SCV" Version="2" SubmitterName="Eurofins Ntd Llc (ga)" OrgID="500060" OrganizationCategory="laboratory" OrgAbbreviation="EGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-01-06">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">EGL Classification Definitions 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/ahdynye1/egl_classification_definitions_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
              <Gender>mixed</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="2" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="2" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ARSA" />
          </GeneList>
          <VariantType>Deletion</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="22" alternateAllele="-" referenceAllele="C" start="51065757" stop="51065757" variantLength="1" />
            <GeneLocation>NM_000487.5:Ex2</GeneLocation>
          </Location>
          <XRefList>
            <XRef DB="dbSNP" ID="774206541" Type="rsNumber" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <Citation>
          <URL>http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=ARSA</URL>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB4534263</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1109360" SubmissionDate="2019-01-29" DateLastUpdated="2017-04-27" DateCreated="2017-04-27">
        <ClinVarSubmissionID localKey="GDX:1520672|Not Provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000574253" DateUpdated="2017-04-27" DateCreated="2017-04-27" Type="SCV" Version="3" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-03-16">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The c.302delG variant in the ARSA gene has been previously reported in an individual with lateinfantile metachromatic leukodystrophy. This individual was also found to be heterozygous foranother variant in the ARSA gene (Chen et al., 2016). The deletion causes a frameshift starting withcodon Glycine 101, changes this amino acid to an Alanine residue and creates a premature Stop codonat position 7 of the new reading frame, denoted p.G101AfsX7. This variant is predicted to cause lossof normal protein function either through protein truncation or nonsense-mediated mRNA decay. Thec.302delG variant is not observed at a significant frequency in large population cohorts (Lek et al.,2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). In summary, we interpret thisvariant as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification (06012015)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/dhtz9flo/genedx_interprules_final_061215.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ARSA" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000487.5:c.302delG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5098196</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="8328538" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2024-02-20">
        <ClinVarSubmissionID localKey="5901334|MedGen:C0023522" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004539156" DateUpdated="2024-02-20" DateCreated="2024-02-20" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-10-22">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">8962139</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">10477432</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Gly101Alafs*7) in the ARSA gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ARSA are known to be pathogenic (PMID: 8962139, 10477432). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This variant has not been reported in the literature in individuals affected with ARSA-related conditions. ClinVar contains an entry for this variant (Variation ID: 424445). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ARSA" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000022.10:g.51065757del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0023522" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14200314</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1109360" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1377095" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8328538" TraitType="Disease" MappingType="XRef" MappingValue="C0023522" MappingRef="MedGen">
        <MedGen CUI="C0023522" Name="Metachromatic leukodystrophy" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

